Chen DS - Search Results

1

Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis.

Liu CH, Peng CY, Fang YJ, Kao WY, Yang SS, Lin CK, Lai HC, Su WP, Fang SU, Chang CC, Su TH, Liu CJ, Chen PJ, Chen DS, Kao JH. Liu CH, et al. Among authors: chen ds, chen pj. Sci Rep. 2020 Jun 8;10(1):9180. doi: 10.1038/s41598-020-66182-8. Sci Rep. 2020. PMID: 32513953 Free PMC article.

2

Mutations in the NS5A and E2-PePHD regions of hepatitis C virus genotype 1b and response to combination therapy of interferon plus ribavirin.

Yang SS, Lai MY, Chen DS, Chen GH, Kao JH. Yang SS, et al. Among authors: chen gh, chen ds. Liver Int. 2003 Dec;23(6):426-33. doi: 10.1111/j.1478-3231.2003.00875.x. Liver Int. 2003. PMID: 14986817

3

Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C.

Liu CJ, Jeng YM, Chen PJ, Lai MY, Yang HC, Huang WL, Kao JH, Chen DS. Liu CJ, et al. Among authors: chen ds, chen pj. Antivir Ther. 2005;10(3):405-15. Antivir Ther. 2005. PMID: 15918331

4

Therapeutic implications of hepatitis B virus genotypes.

Liu CJ, Kao JH, Chen DS. Liu CJ, et al. Among authors: chen ds. Liver Int. 2005 Dec;25(6):1097-107. doi: 10.1111/j.1478-3231.2005.01177.x. Liver Int. 2005. PMID: 16343058 Review.

5

Natural course and treatment of dual hepatitis B virus and hepatitis C virus infections.

Liu CJ, Liou JM, Chen DS, Chen PJ. Liu CJ, et al. Among authors: chen ds, chen pj. J Formos Med Assoc. 2005 Nov;104(11):783-91. J Formos Med Assoc. 2005. PMID: 16496056 Review.

6

Pegylated interferon-alpha-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: a multicenter, randomized controlled trial.

Liu CH, Liu CJ, Lin CL, Liang CC, Hsu SJ, Yang SS, Hsu CS, Tseng TC, Wang CC, Lai MY, Chen JH, Chen PJ, Chen DS, Kao JH. Liu CH, et al. Among authors: chen jh, chen ds, chen pj. Clin Infect Dis. 2008 Nov 15;47(10):1260-9. doi: 10.1086/592579. Clin Infect Dis. 2008. PMID: 18834319 Clinical Trial.

7

Factors affecting early viral load decline of Asian chronic hepatitis C patients receiving pegylated interferon plus ribavirin therapy.

Hsu CS, Liu CH, Liu CJ, Chen CL, Lai MY, Chen PJ, Chen DS, Kao JH. Hsu CS, et al. Among authors: chen ds, chen cl, chen pj. Antivir Ther. 2009;14(1):45-54. Antivir Ther. 2009. PMID: 19320236

8

Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C.

Liu CH, Liang CC, Liu CJ, Lin JW, Chen SI, Hung PH, Tsai HB, Lai MY, Chen PJ, Chen DS, Kao JH. Liu CH, et al. Among authors: chen ds, chen si, chen pj. Clin Infect Dis. 2010 Sep 1;51(5):541-9. doi: 10.1086/655682. Clin Infect Dis. 2010. PMID: 20645865 Clinical Trial.

9

Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial.

Liu CH, Liu CJ, Huang CF, Lin JW, Dai CY, Liang CC, Huang JF, Hung PH, Tsai HB, Tsai MK, Lee CY, Chen SI, Yang SS, Su TH, Yang HC, Chen PJ, Chen DS, Chuang WL, Yu ML, Kao JH. Liu CH, et al. Among authors: chen ds, chen si, chen pj. Gut. 2015 Feb;64(2):303-11. doi: 10.1136/gutjnl-2014-307080. Epub 2014 Apr 19. Gut. 2015. PMID: 24747867 Clinical Trial.

10

Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy.

Liang CC, Liu CH, Chung CS, Lin CK, Su TH, Yang HC, Liu CJ, Chen PJ, Chen DS, Kao JH. Liang CC, et al. Among authors: chen ds, chen pj. J Infect Dis. 2015 May 1;211(9):1429-36. doi: 10.1093/infdis/jiu630. Epub 2014 Nov 11. J Infect Dis. 2015. PMID: 25387585

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,033 results

Search Page